Table 2.
Factor | IQR | Residual risk associations after accounting for mGFR | |||
---|---|---|---|---|---|
eGFRcr | eGFRcys | eGFRB2M | eGFRBTP | ||
AGES-Kidney (N=683) | |||||
Age (year) | 5 | 6.5 (4.5, 8.4) | 2.1 (0.6, 3.6)* | 2.9 (1.3, 4.5)* | 3.2 (1.5, 4.9)* |
Female (vs. Male) | - | 22.8 (20.4, 25.3) | 7.1 (5.0, 9.3)* | 6.1 (3.7, 8.4)* | 9.6 (7.1, 12.2)* |
Black (vs. not Black) | NA | - | - | - | - |
MESA-Kidney (N=275) | |||||
Age (year) | 15 | 16.7 (12.6, 20.8) | 5.3 (2.1, 8.6)* | 7.1 (3.8, 10.5) * | 7.4 (3.7, 11.1)* |
Female (vs. Male) | - | 25.9 (21.5, 30.4) | 14.0 (10.5, 17.5)* | 10.2 (6.4, 14.0)* | 16.1 (11.8, 20.3)* |
Black (vs. not Black) | - | −7.9 (−13.2, −2.5) | 0.8 (−3.1, 4.7)* | 3.8 (−0.2, 7.8) * | 2.8 (−1.9, 7.5)* |
Note: Unadjusted residual associations estimated using stacked generalized estimating equations. Creatinine, cystatin C, BTP, and B2M were transformed to the eGFR scale using study- specific equations based on each serum filtration marker. Associations can be interpreted as a percent difference since mGFR and eGFR are expressed as natural log transformations.
Residual association vs. residual association for eGFRcr p<0.05